DanielJHarafMD
Radiation Oncology • Chicago, ILProfessor and medical director, Radiation Oncology University of Chicago
Dr. Haraf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-0610
Summary
- Dr. Daniel Haraf is a radiation oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including University of Chicago Medical Center and University of Illinois Hospital & Health Sciences System. He received his medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 35 years. He is experienced in lung cancer, neck pain, and head and neck radiation oncology.
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1985 - 1988
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1984
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1982
Certifications & Licensure
IL State Medical License 1983 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing Start of enrollment: 2018 Jan 22
Publications & Presentations
PubMed
- 1 citationsNeoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial.Ari J Rosenberg, Nishant Agrawal, Aditya Juloori, John Cursio, Zhen Gooi
JAMA Oncology. 2024-07-01 - Laryngotracheal Resection After B-Raf Proto-oncogene Inhibition for Anaplastic Thyroid Carcinoma.Johnathan Kent, Philip Erwin, Daniel Haraf, Chih-Yi Liao, Joseph Durham
The Annals of Thoracic Surgery. 2023-05-01 - 2 citationsPhase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamou...Ari J Rosenberg, Nishant Agrawal, Alexander T Pearson, Zhen Gooi, Elizabeth Blair
British Journal of Cancer. 2022-11-01
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Other
- Paranasal sinus cancerHaraf DJ, Stenson KM
http://www.uptodate.com/contents/paranasal-sinus-cancer
UpToDate, Wolters Kluwer Health - 2012-04-06 - Reirradiation for locally recurrent head and neck cancerHaraf DJ, Salama JK, Milano MT
http://www.uptodate.com/contents/reirradiation-for-locally-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-07-20 - Treatment of locally recurrent head and neck cancerHaraf DJ, Milano MT, Chmura SJ
http://www.uptodate.com/contents/treatment-of-locally-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-08-29
Press Mentions
First He Survived Cancer – Now He Studies ItNovember 14th, 2022
Grant Support
- Core--Biostatistics, Data Management And ClinicalNational Institute Of Dental &Craniofacial Research1996–2001
- Core--Clinical Trial Protocol Review And Monitoring SystemNational Cancer Institute1996–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
